146 related articles for article (PubMed ID: 28716526)
1. SLC45A3-ELK4 functions as a long non-coding chimeric RNA.
Qin F; Zhang Y; Liu J; Li H
Cancer Lett; 2017 Sep; 404():53-61. PubMed ID: 28716526
[TBL] [Abstract][Full Text] [Related]
2. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation.
Zhang Y; Gong M; Yuan H; Park HG; Frierson HF; Li H
Cancer Discov; 2012 Jul; 2(7):598-607. PubMed ID: 22719019
[TBL] [Abstract][Full Text] [Related]
3. Role of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA.
Qin F; Song Y; Zhang Y; Facemire L; Frierson H; Li H
PLoS One; 2016; 11(3):e0150382. PubMed ID: 26938874
[TBL] [Abstract][Full Text] [Related]
4. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA
Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179
[TBL] [Abstract][Full Text] [Related]
5. SLC45A3-ELK4 chimera in prostate cancer: spotlight on cis-splicing.
Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
Cancer Discov; 2012 Jul; 2(7):582-5. PubMed ID: 22787087
[TBL] [Abstract][Full Text] [Related]
6. Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?
Ren G; Zhang Y; Mao X; Liu X; Mercer E; Marzec J; Ding D; Jiao Y; Qiu Q; Sun Y; Zhang B; Yeste-Velasco M; Chelala C; Berney D; Lu YJ
OMICS; 2014 Oct; 18(10):615-24. PubMed ID: 25188740
[TBL] [Abstract][Full Text] [Related]
7. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.
Makkonen H; Jääskeläinen T; Pitkänen-Arsiola T; Rytinki M; Waltering KK; Mättö M; Visakorpi T; Palvimo JJ
Oncogene; 2008 Aug; 27(36):4865-76. PubMed ID: 18469865
[TBL] [Abstract][Full Text] [Related]
8. A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells.
Lai J; Lehman ML; Dinger ME; Hendy SC; Mercer TR; Seim I; Lawrence MG; Mattick JS; Clements JA; Nelson CC
RNA; 2010 Jun; 16(6):1156-66. PubMed ID: 20406994
[TBL] [Abstract][Full Text] [Related]
9. Novel transcription-induced fusion RNAs in prostate cancer.
Zhao S; Løvf M; Carm KT; Bakken AC; Hoff AM; Skotheim RI
Oncotarget; 2017 Jul; 8(30):49133-49143. PubMed ID: 28467780
[TBL] [Abstract][Full Text] [Related]
10. Fusion transcript detection using spatial transcriptomics.
Friedrich S; Sonnhammer ELL
BMC Med Genomics; 2020 Aug; 13(1):110. PubMed ID: 32753032
[TBL] [Abstract][Full Text] [Related]
11. Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.
Perner S; Rupp NJ; Braun M; Rubin MA; Moch H; Dietel M; Wernert N; Jung K; Stephan C; Kristiansen G
Int J Cancer; 2013 Feb; 132(4):807-12. PubMed ID: 22821757
[TBL] [Abstract][Full Text] [Related]
12. Discovery of CTCF-sensitive Cis-spliced fusion RNAs between adjacent genes in human prostate cells.
Qin F; Song Z; Babiceanu M; Song Y; Facemire L; Singh R; Adli M; Li H
PLoS Genet; 2015 Feb; 11(2):e1005001. PubMed ID: 25658338
[TBL] [Abstract][Full Text] [Related]
13. TRA2A-induced upregulation of LINC00662 regulates blood-brain barrier permeability by affecting ELK4 mRNA stability in Alzheimer's microenvironment.
Liu Q; Zhu L; Liu X; Zheng J; Liu Y; Ruan X; Cao S; Cai H; Li Z; Xue Y
RNA Biol; 2020 Sep; 17(9):1293-1308. PubMed ID: 32372707
[TBL] [Abstract][Full Text] [Related]
14. Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset.
Hernández S; Font-Tello A; Juanpere N; de Muga S; Lorenzo M; Salido M; Fumadó L; Serrano L; Cecchini L; Serrano S; Lloreta J
Prostate; 2016 Jun; 76(9):854-65. PubMed ID: 26959281
[TBL] [Abstract][Full Text] [Related]
15. Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer.
Qin F; Song Z; Chang M; Song Y; Frierson H; Li H
Cancer Lett; 2016 Sep; 380(1):39-46. PubMed ID: 27322736
[TBL] [Abstract][Full Text] [Related]
16. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
Helgeson BE; Tomlins SA; Shah N; Laxman B; Cao Q; Prensner JR; Cao X; Singla N; Montie JE; Varambally S; Mehra R; Chinnaiyan AM
Cancer Res; 2008 Jan; 68(1):73-80. PubMed ID: 18172298
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA NORAD induces cell proliferation and migration in prostate cancer.
Zhang H; Guo H
J Int Med Res; 2019 Aug; 47(8):3898-3904. PubMed ID: 31342822
[TBL] [Abstract][Full Text] [Related]
18. Retention of Interstitial Genes between
Murphy SJ; Kosari F; Karnes RJ; Nasir A; Johnson SH; Gaitatzes AG; Smadbeck JB; Rangel LJ; Vasmatzis G; Cheville JC
Cancer Res; 2017 Nov; 77(22):6157-6167. PubMed ID: 29127096
[No Abstract] [Full Text] [Related]
19. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
[TBL] [Abstract][Full Text] [Related]
20. Androgen regulation of ETS gene fusion transcripts in prostate cancer.
Gasi D; Trapman J
Methods Mol Biol; 2011; 776():335-48. PubMed ID: 21796535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]